Medinice S.A. — M&A Activity 2026

Jan 23, 2026

Report Content The Management Board of Medinice S.A. (the "Company") announces that onJanuary 22, 2026, the Company signed a Letter of Intent ("LoI") with aninternational entity active in the cardiac surgery market, concerningthe potential sale of the CoolCryo project.

According to the LoI, the planned transaction would include the sale ofrights to the CoolCryo project along with global patent protection, witha particular focus on the territories of Europe and the United States.

The detailed terms of the transaction, including the final sales priceand payment terms, will be specified in the definitive agreement. Theparties have agreed to make every effort to conclude the final agreementwithin 3 months of the signing of the LOI.

This information is being provided because the ongoing negotiations mayresult in significant changes to the Issuer's asset structure, whichcould potentially have a significant impact on its financial situationand asset valuation.The company will inform about any furthermaterial arrangements regarding the transaction in question by means ofrelevant current reports, should such an information disclosureobligation arise.